Showing results (91-100 of 175) with videos related to
Sort By:
Pageof 18
Oncogene|August 12, 1999
An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradationE T Bowden, M Barth, D Thomas, et al.Journal of Pediatric Surgery|February 16, 2017
Sutures impregnated with carbazate-activated polyvinyl alcohol reduce intraperitoneal adhesionsF Fredriksson, F Sellberg, T Bowden, et al.Journal of Cellular Biochemistry. Supplement|January 1, 1992
New relationships between prostatic intraepithelial neoplasia and prostatic carcinomaR B Nagle, M Petein, M Brawer, et al.Experimental Cell Research|November 1, 1995
Degradation of fibronectin fibrils by matrilysin and characterization of the degradation productsD C von Bredow, R B Nagle, G T Bowden, et al.Oncogene|May 29, 1997
Regulation of DNA binding and transactivation in p53 by nuclear localization and phosphorylationJ D Martinez, M T Craven, E Joseloff, et al.Carcinogenesis|October 1, 1991
Comparison of ras activation during epidermal carcinogenesis in vitro and in vivoM Quintanilla, S Haddow, D Jonas, et al.Cancer Research|October 1, 1985
Comparative molecular pharmacology in leukemic L1210 cells of the anthracene anticancer drugs mitoxantrone and bisantreneG T Bowden, R Roberts, D S Alberts, et al.The Prostate|June 3, 1998
Synthetic matrix metalloproteinase inhibitor, BB-94, inhibits the invasion of neoplastic human prostate cells in a mouse modelJ D Knox, L Bretton, T Lynch, et al.Molecular Carcinogenesis|February 5, 2000
Inhibition of atypical PKC blocks ultraviolet-induced AP-1 activation by specifically inhibiting ERKs activationC Huang, J Li, N Chen, et al.Experimental Cell Research|November 5, 1997
Cleavage of beta 4 integrin by matrilysinD C von Bredow, R B Nagle, G T Bowden, et al.Pageof 18